Read More Apparatus Hutchison Pharmaceuticals Announces Approval Of Cd73 Monoclonal Antibody Mupadolimab In Phase I/Ib Clinical Trial In China Nov 13, 2024
Read More Medical Significant Improvement In Survival For Pancreatic Cancer Patients! A first-Line NALIRIFOX Regimen To Look Forward To! Nov 23, 2024
Read More Medical Study Shows That a Blood Pressure Drug Combined With Radiotherapy Improves Outcomes In Locally Advanced Pancreatic Cancer Nov 16, 2024
Read More Apparatus Heavyweight! First ADC Drug For Refractory Ovarian Cancer Receives Accelerated FDA Approval Nov 03, 2024
